Crime & Safety

Dedham Couple Sentenced in NECC Meningitis Case

Dougal and Carla Conigliaro were sentenced to probation and a fine.

DEDHAM, MA —The majority owner of New England Compounding Center and her husband were sentenced Wednesday in U.S. District Court in Boston in connection with illegally withdrawing cash following the 2012 fungal meningitis outbreak.

Carla Conigliaro, 53, of Dedham, the majority owner of NECC was sentenced to one year of probation and ordered to pay a fine of $4,500. Her husband, Douglas Conigliaro, 55, also of Dedham, was sentenced to two years of probation and ordered to pay a fine of $55,000, according to the U.S. Attorney's office.

In July both pleaded guilty to withdrawing cash from their bank accounts in a manner intended to defeat financial reporting requirements.

Find out what's happening in Dedhamfor free with the latest updates from Patch.

In September 2012, a nationwide outbreak of fungal meningitis was traced back to contaminated vials of preservative-free methylprednisolone acetate (MPA) manufactured by NECC, a compounding pharmacy located in Framingham. Beginning on Oct. 31, 2012, the day a search warrant was executed at NECC, Carla and Douglas Conigliaro began withdrawing unusual sums of cash from their personal bank accounts. The cash transactions were structured by the Conigliaros in a manner so as to evade the $10,000 reporting requirement for the filing of a currency transaction report. The Conigliaros admitted to withdrawing $124,000 in cash in this manner.

In December 2014, following a two-year investigation, the Conigliaros and 12 other employees and associates of NECC were charged in a federal indictment. The indictment did not charge the Conigliaros with having an active role in the operations or management of NECC, but did charge them with transferring assets following the fungal meningitis outbreak.

Find out what's happening in Dedhamfor free with the latest updates from Patch.

NECC’s owner and head pharmacist Barry J. Cadden and supervisory pharmacist Glenn A. Chin were charged with 25 racketeering acts of second-degree murder in seven states. Ten other defendants, including six pharmacists, the director of operations, the national sales director, an unlicensed pharmacy technician, and another owner, were charged with additional crimes including racketeering, mail fraud, conspiracy, and violations of the Food, Drug and Cosmetic Act.

Cadden and Chin are scheduled to stand trial on Jan. 5, 2017.

Information in this article was provided by the U.S. Attorney's office.

Photo via Dedham Police Department

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.